Sitagliptin and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Sitagliptin (sitagliptin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Fainting when taking Sitagliptin. It is created by eHealthMe based on reports of 3,929 people who have side effects when taking Sitagliptin from the FDA, and is updated regularly.

What is Sitagliptin?

Sitagliptin has active ingredients of sitagliptin. eHealthMe is studying from 3,933 Sitagliptin users. Check the latest studies of Sitagliptin.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,463 drugs and 3,546 conditions by eHealthMe. Check the latest studies of Fainting.

On Jul, 06, 2026

3,929 people reported to have side effects when taking Sitagliptin.
Among them, 51 people (1.3%) have Fainting.

Among these 51 people:

How long have people been on Sitagliptin when they have Fainting? *

What is the gender of people who have Fainting when taking Sitagliptin? *

female: 89.58 %
male: 10.42 %

What is the age of people who have Fainting when taking Sitagliptin? *

What are other drugs people take besides Sitagliptin? *

What are other side effects people have besides Fainting? *

Dehydration (dryness resulting from the removal of water): 25 people, 49.02%
Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 24 people, 47.06%
Intracranial Aneurysm (bulging, weak area in the wall of a cranial artery): 15 people, 29.41%
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 13 people, 25.49%
Respiratory Syncytial Virus Infection (viral disease of respiratory system): 9 people, 17.65%
Hyperkalemia (damage to or disease of the kidney): 8 people, 15.69%
Dizziness: 8 people, 15.69%
Carotid Artery Thrombosis (blood clot in carotid artery): 7 people, 13.73%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 7 people, 13.73%
Abdominal Pain: 7 people, 13.73%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 25 people, 49.02%
Type 2 Diabetes: 4 people, 7.84%
High Blood Pressure: 4 people, 7.84%
Pain: 3 people, 5.88%
Vitamin B1 Decreased: 2 people, 3.92%
Blood Magnesium Decreased: 2 people, 3.92%
Cellulitis (infection under the skin): 2 people, 3.92%
Chronic Kidney Disease: 2 people, 3.92%
Diabetes: 2 people, 3.92%
Dyslipidaemia (abnormal amount of lipids): 2 people, 3.92%

* Approximation only. Some reports may have incomplete information.

Do you take Sitagliptin and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sitagliptin:

Sitagliptin (3,933 reports)

Fainting treatments and more:

Fainting (131,321 reports)

Browse all side effects of Sitagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,463 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,546 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin (the active ingredients of Sitagliptin) and Sitagliptin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.